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Protein evolution
On the origin of 
proteins 
A series of mistakes over the past 3.7 billion years or so has left us with a spectacular 
array of protein structures and functions, which are responsible for nothing less 
than life itself, writes Bea Perks 
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Evolution tends to be thought of 
at the level of species – from the 
evolution of flowering plants to the 
‘ascent’ of man. Charles Darwin 
kicked it all off 150 years ago with the 
publication of On the origin of species. 
Darwin’s theory hasn’t changed, but 
what we now know, from research 
grounded on the foundations he 
laid, has dramatically changed the 
level at which we can think about 
evolution. That’s not to say that 
studying evolution at the species level 
is reserved for the history books, but 
there is a relatively new and steadily 
growing approach to evolution: 
evolution at the molecular level.
At a very basic level, we 
understand that evolution follows  
the accumulation of beneficial 
mutations in a gene sequence. 
Most of the time, gene mutations 
are detrimental. These are quickly 
removed by natural selection. But 
just occasionally, a mutation might 
improve (or at least not harm) an 
organism’s chance of survival. When 
that happens, the mutation will pass 
to the next generation. Evolution, 
over hundreds, thousands, millions 
and billions of years, has generated 
life as we know it. But while there is 
much talk of evolution on the macro 
scale – from the evolution of whole 
species to that of eyes or opposable 
thumbs – there has been relatively 
little mention of the molecular 
evolution that has underpinned  
these observable changes.
Protein evolution
On top of what we already know 
about evolution, researchers now 
have an eye-watering volume of 
gene and protein sequence data 
to hand. It is therefore becoming 
possible, using that data, to trace the 
evolution of proteins through time. Of 
course, sequence data alone cannot 
yield insight into the functions and 
structures of ancient proteins, or the 
processes by which their descendants 
evolved. But in the latest approach to 
the problem, scientists have begun 
to reconstruct ancient proteins and 
trace how they are most likely to have 
changed throughout evolutionary 
history to produce today’s proteins. 
Joseph Thornton, an evolutionary 
and molecular biologist at the 
University of Oregon, US, and his 
team have shown how evolution 
tinkered with early proteins, and 
leaves the impression that complexity 
has evolved many times over. 
Human and other animal cells 
contain thousands of proteins with 
functions so diverse and complex 
that it can be difficult to see how 
they might have evolved from a few 
ancestral proteins, says Thornton. His 
team recently studied the large family 
of nuclear receptors,1 which regulate 
key biological processes in animals 
by binding to specific DNA sequences 
and triggering the expression 
of nearby target genes. Nuclear 
receptors respond to hormones, 
nutrients and other chemical 
signals to regulate development, 
reproduction, metabolism and cancer.
There are some nuclear receptors 
that do not have to be activated by a 
chemical signal: they can trigger gene 
expression on their own. The received 
wisdom has held that the ancestral 
protein of today’s nuclear receptors 
would have been of this simpler type, 
implying that the complex capacity 
to bind and be regulated by chemical 
signals evolved independently in 
many lineages.
Using a database of the molecular 
sequences, functions, and atomic 
structures of hundreds of modern-
day nuclear receptor proteins – from 
those found in sponges to those 
found in man – Thorton’s team 
reconstructed the biochemical 
characteristics of the ancestral 
nuclear receptor, which would have 
existed before the last common 
ancestor of all animals on earth – as 
much as a billion years ago.
The missing link
Finding an ‘early’ nuclear receptor 
was tricky, because nuclear receptors 
are not found in all organisms. They 
are not found in plants or fungi; and 
nearly all the animal species that are 
known to have nuclear receptors, and 
whose genomes have been sequenced, 
have rather diverse selections of 
receptors – so they provide little 
information about which 
receptor genes were the first to evolve 
and which appeared later.
Luckily for Thornton, the 
genome of the sponge Amphimedon 
queenslandica was also published 
in 2010. Thornton’s team found 
that the A. queenslandica genome 
contains only two nuclear receptors 
(as opposed to the diverse selection 
in previously sequenced genomes), 
which they called AqNR1 and AqNR2.   
His team also identified nuclear 
receptors in the genomes of two other 
recently sequenced species from the 
relatively distant evolutionary past: 
a curious flat, tiny (1mm diameter) 
animal called Trichoplax adhaerens 
and the sea anemone Nematostella 
vectensis, which contain four and 
17 nuclear receptors respectively. 
Thornton concludes that, given 
the limited nuclear receptor 
diversification in these three separate 
species and knowing where each 
of them appeared in evolutionary 
history, these animals can shed light 
on early nuclear receptor evolution.
By reconstructing the family tree 
of nuclear receptor genes, Thornton 
found that AqNR1 represents the 
anciently diverged sister lineage to 
virtually all other nuclear receptors. 
Using a battery of biochemical 
and molecular assays, Thornton’s 
group showed that AqNR1 requires 
activation by a fatty acid. They also 
used computational methods to 
predict the three-dimensional atomic 
structure of the sponge proteins. This 
showed that they bound the fatty acid 
in a cavity very similar to that found in 
some receptors in mammals.
Thornton then worked his way 
backwards down the gene family 
phylogeny, computationally tracing 
features of the architecture and 
functions of nuclear receptor 
proteins back through their 
common ancestors, all the way to 
the progenitor of the entire receptor 
family, which existed in the very first 
animal perhaps a billion years ago. He 
found, contrary to current received 
wisdom, that the ancestral receptor 
required activation by a chemical 
signal – probably a fatty acid.
The underlying atomic 
mechanisms that allowed the 
ancestral protein to be activated by 
chemical signals are conserved in 
virtually all present-day descendants. 
In other words, it wasn’t a complex 
capacity that had to be evolved in 
many lineages further down the 
evolutionary line, but one that has 
been lost by a few. By analysing 
the structures of diverse nuclear 
receptors and comparing them to 
the ancestral template, Thornton’s 
In short
 A profusion of genetic 
and protein sequence 
data has opened up 
studies of evolution on 
the molecular level
 Tracing the sequence 
of mutations in a protein 
can show how its 
structure and function 
evolved over time
 Directed evolution in 
the laboratory can give 
insights into structure-
function relationships 
and create new proteins 
with functions not seen 
in nature
Thornton’s reconstructed 
ancestral nuclear 
receptor was probably 
activated by a fatty acid 
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Protein evolution
team traced in detail how evolution 
tweaked the ancestral structure over 
time to yield new functions.
They found that in many receptor 
lineages, a few mutations subtly 
changed the size and shape of 
the cavity where the signalling 
compound binds, causing receptors 
to evolve partnerships with 
hormones or other new signals.
Other members of the receptor 
family became independent of 
chemical signals; these proteins, like 
switches stuck in the ‘on’ position, 
evolved when simple mutations 
increased the intrinsic stability of 
the protein’s active conformation, 
removing the need for a chemical 
signal to activate gene expression.
Ancestral complexity
‘If you just compare the receptors in 
modern humans, the evolutionary 
events by which they could have 
evolved are not obvious. It may look 
as if the complex functions of each 
protein evolved independently,’ says 
Thornton. ‘But when we traced these 
proteins from their ancestor through 
time, we saw how evolution tinkered 
with the ancestral form, producing 
an incredible diversity of protein 
functions and the ability to interact 
with many different chemical signals.’ 
Nuclear receptors are a ‘great 
case study in protein evolution’, 
says Thornton, adding that it is 
likely that other protein families, 
when studied in similar detail, 
will turn out to have diversified 
by a similar kind of tinkering. ‘We 
predict that, when sufficient data 
are gathered to allow detailed 
evolutionary reconstructions, it 
will become apparent that most 
protein superfamilies diversified 
by subtle modification and partial 
degradation of ancient, deeply 
homologous functions. Invoking the 
evolution of wholesale ‘‘novelty’’ 
will seldom be necessary.’1
That’s all very interesting, of 
course, but is it really useful? Very 
much so, Thornton explains: 
‘Structure-function relationships are 
the fundamental object of knowledge 
in protein chemistry; they allow us 
to rationally design drugs, engineer 
proteins with new functions, and 
understand why mutations cause 
disease.’ Unfortunately, revealing how 
the sequence of a protein determines 
its function using traditional 
laboratory manipulations is difficult, 
because the number of possible 
sequence variations in any protein 
family is too great. ‘The solution lies 
in studying evolution, which has been 
a massively parallel experiment in 
diversifying and optimising proteins, 
conducted over vast periods of time’ 
says Thornton.
One person who has found protein 
evolution both interesting and 
useful is Frances Arnold, a chemical 
engineer at California Institute of 
Technology (Caltech) in Pasadena, 
US. Arnold, together with Willem 
‘Pim’ Stemmer, chief executive of the 
Californian biopharmaceutical firm 
Amunix, has just been awarded  
the Charles Stark Draper prize – 
widely considered the equivalent  
of the Nobel prize for engineering  
in the US – for developing  
directed evolution: ‘a method  
used worldwide for engineering 
novel enzymes and biocatalytic 
processes for pharmaceutical and 
chemical products.’
Inspired by the real-life evolution 
of proteins, Arnold developed a 
system that literally ‘directs’ the 
evolution of proteins by repeated 
rounds of mutation and selection. 
‘Evolution happens by the 
accumulation of beneficial mutations 
one at a time through functional 
proteins,’ says Arnold. ‘And that’s 
a very simple algorithm; it doesn’t 
require that you screen large numbers 
of things if you can go through single 
mutational stops.’
Mimicking evolution
Arnold began to evolve proteins 
by randomly mutating the gene 
of a known protein, screening its 
mutant offspring a few-hundred or a 
few-thousand at a time, finding one 
beneficial mutation, and repeating 
the process starting from that mutant 
gene. ‘That’s just mimicking how 
adaptive evolution happens,’ she says. 
‘It doesn’t fully mimic it, because 
we miss the entire neutral mutation 
pathways,’ she says, ‘but people 
are starting to try to insert neutral 
mutations into directed evolution 
as well.’ Neutral mutations will be 
passed on from one generation to 
the next if they pose no threat to an 
organism’s survival. They shouldn’t 
be ignored because, further on down 
the line, they might help give rise to a 
beneficial mutation.
Another important lesson from 
adaptive, real-life, evolution has come 
from recognising which proteins and 
what functions are evolvable. ‘We’ve 
learnt that the proteins that evolve 
Proteins with flexible 
conformations, like this 
sugar-binding lectin, are 
more likely to evolve a 
wide variety of functions
Nuclear receptor 
evolution has been 
traced in the sea 
anemone N. vectensis 
and other species from 
the relatively distant 
evolutionary past
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readily in nature also evolve readily in 
the laboratory,’ says Arnold.
‘For example, secondary metabolic 
pathway enzymes, like cytochrome 
P450s and other enzymes whose 
specificities and functions have 
varied all over the map tend to readily 
change in the laboratory,’ she says. 
‘And the converse is true, proteins 
whose functions have not shown 
great diversity in nature tend to be 
more difficult to engineer’
Arnold comes from what she calls 
an engineering and problem solving 
background. ‘I was looking for the 
most effective means to engineer 
proteins, the sequence basis of whose 
functions we just don’t understand. 
So a rational design pathway to 
achieve very specific functions just 
wasn’t realistic, and evolution seemed 
to be a much more promising route.’
Just as Arnold keeps up with the 
world of natural protein evolution, 
particularly work from Thornton’s 
lab, protein evolutionists are now 
reading the directed evolution work. 
‘We have one huge advantage,’ says 
Arnold, ‘and that’s data.’
Although directed evolution 
started from an engineering 
perspective, researchers from 
different backgrounds and interests 
have come to it specifically to answer 
questions about how proteins 
evolve. ‘If you look at people like 
Joe Thornton or a number of 
people whose primary interest is in 
evolution, they are now using directed 
evolution to try to understand how 
proteins can adapt,’ she says.
The traditional view that proteins 
possess absolute functional specificity 
and a single, fixed structure conflicts 
with their marked ability to adapt and 
evolve new functions and structures, 
says Dan Tawfik of the Weizmann 
Institute of Science in Israel. 
‘Natural selection is yielding 
molecular machines with 
breathtaking performance,’ says 
Tawfik. ‘New functions can evolve 
within years or even months, as 
happens naturally with things like 
drug resistance.’
Tawfik’s team argues that proteins 
exhibit ‘functional promiscuity’, 
which is an essential component of a 
protein’s evolvability. He correlates 
promiscuity with conformational 
diversity. In antibodies, for example, 
increased affinity for a ligand – 
clearly an essential characteristic 
of an antibody – leads to decreased 
binding-site flexibility. Conversely 
the P450s, as mentioned by Arnold, 
demonstrate increased promiscuity 
– relatively broad substrate scope – 
with increasing flexibility. 
But is it really chemistry?
The study of protein evolution lies 
at the interface of chemistry and 
biology, and relies to a large extent 
on engineering. Each discipline can 
claim it as their own, but it is often 
dismissed as ‘not really biology’ or 
‘not really chemistry’.
It’s definitely chemistry, 
says Arnold the engineer, who 
nevertheless files directed evolution 
firmly under ‘synthetic biology’. 
Apart from anything else, scientists 
have a habit for winning Nobel prizes 
in chemistry for work on proteins.
Back in 1946, the Nobel prize in 
chemistry went to James Sumner 
of Cornell University, US, who won 
half the prize ‘for his discovery that 
enzymes can be crystallised’; and 
John Northrop together with Wendell 
Stanley, both of the Rockefeller 
Institute for Medical Research in 
Princeton, US, shared the other half 
‘for their preparation of enzymes and 
virus proteins in a pure form’. 
In 1972, half the chemistry Nobel 
prize went to Christian Anfinsen 
of the US National Institutes of 
Health with the other half shared by 
Stanford Moore and William Stein, 
both from Rockefeller University 
in New York, US, for fundamental 
work in protein chemistry. Anfinsen 
had shown that the information for 
a protein assuming a specific three-
dimensional structure is inherent 
in its amino acid sequence, which 
was the starting point for studies 
of protein folding. Moore and Stein 
received the prize for discovering 
anomalous properties of functional 
groups in an enzyme’s active site, as a 
result of the protein fold.
In 2009, the prize went to 
Venkatraman Ramakrishnan, Thomas 
Steitz and Ada Yonath ‘for studies 
of the structure and function of the 
ribosome’. In 2008 it was awarded 
jointly to Osamu Shimomura, Martin 
Chalfie and Roger Tsien ‘for the 
discovery and development of the 
green fluorescent protein, GFP’.
On Frances Arnold’s website,3 team 
members have contributed to a ‘How 
would you explain synthetic biology 
to Darwin?’ section.
In Arnold’s words: ‘You had it 
just right! And now I can build new 
components of life – for example, 
the proteins of which we are made 
– by artificial selection. When I 
decide who gets to reproduce, 
these components evolve just like 
the organisms that make them do, 
because they are encoded by the same 
stuff and follow the same principles  
of evolution that you showed us 
for all forms of life.’
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‘Natural 
selection 
is yielding 
molecular 
machines with 
breathtaking 
performance’
Christian Anfinsen 
one of a host of protein 
scientists who have 
claimed the Nobel prize 
for chemistry
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